ArticleArchives of dermatological research2025
Comparative study between combined follicular and epidermal cell suspension versus epidermal cell suspension in treatment of stable vitiligo.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Hair Follicle Stem Cells: Emerging Physiology and Therapeutic Applications.Stem cell reviews and reports · 2026Review
- Vitiligo as a Failure of Immune Resolution and Tissue Regeneration: From Stress Signals to Targeted Immune Modulation.Clinical reviews in allergy & immunology · 2026Review
- Recent Advances in Vitiligo Treatment.ImmunoTargets and therapy · 2026Review
- Injectable crosslinked HA hydrogel: a promising carrier for cell transplantation to treat stable vitiligo.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent developments in the treatment of vitiligo focus on minimizing adverse effects while also reducing the overall treatment duration. This work aimed to compare the advantages and limitations of epidermal cell transplantation versus combined epidermal and follicular cell transplantation in the treatment of stable vitiligo. This study was conducted on 20 vitiligo patients, aged between 15 and 50 years, all of whom presented with symmetrical lesions. The first lesion was treated with epidermal cell suspension (ECS), while the second lesion received a combined treatment of ECS and follicular cell suspension (FCS). The third lesion served as the control. A notable improvement in pigmentation was observed in the combined treatment group compared to the epidermal treatment group. Control patches exhibited resistance to NB-UVB therapy, showing minimal improvement and a slight reduction in depigmentation, in contrast to the treated patches. A significant correlation was found between the site of vitiligo, the tensity stages of the vitiligo extent tensity index (VETI) score after treatment, and the percentage of improvement (P < 0.05). Additionally, a significant relationship was observed between the vitiligo area severity index score and the tensity stages of the VETI score after treatment, as well as the percentage of improvement (P < 0.05). The combination of ECS and FCS as an innovative approach in vitiligo surgery, achieving good to excellent repigmentation within a short period. This method also ensures a favorable color match, even in cases of vitiligo that are typically resistant to treatment.
Indexed as
Identifiers
39937279What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.